Etorite Tablet ER contains Etodolac 600mg, a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. Etodolac works by inhibiting the cyclooxygenase (COX) enzymes, which play a key role in the synthesis of prostaglandins responsible for pain and inflammation. The extended-release (ER) formulation ensures a sustained release of the medication, providing prolonged therapeutic effects and allowing for convenient once or twice-daily dosing. This helps in maintaining consistent blood levels of the drug, improving symptom control and patient compliance. Etorite Tablet ER is indicated for managing moderate to severe pain and inflammation, improving joint function, and enhancing quality of life in affected individuals. It should be taken with food or milk to minimize gastrointestinal discomfort, a common side effect of NSAIDs. Patients with a history of peptic ulcers, cardiovascular diseases, or renal impairment should use this medication cautiously and under medical supervision. Common adverse effects may include nausea, dizziness, and gastrointestinal upset. It is important to follow the prescribed dosage and consult a healthcare professional before starting or discontinuing therapy to ensure safe and effective use of Etorite Tablet ER.